Arginine methylation of human DNA topoisomerase I by PRMT5 facilitates DNA relaxation
Nucleic Acids Research · 20.05.2026 · 54 (10)
DOI: 10.1093/nar/gkag503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 30.05.2026. Verfasst von Saini Basu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, School of Biological Sciences, Indian Association for the Cultivation of Science, 2A & B, Raja S. C. Mullick Road, J…. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, DNA Topoisomerases, Type I, Arginine. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANRF, ICMR, IACS.
Abstract (Originalsprache)
DNA topoisomerase 1 (Top1) is essential for resolving DNA supercoiling during replication and transcription. Here, we identify protein arginine methyltransferase 5 (PRMT5) as a novel regulator of human Top1 activity via symmetric dimethylation at arginine residues R708 and R749, located in the linker and catalytic domains, respectively. Methylation enhances Top1-mediated strand rotation and DNA relaxation without affecting its DNA binding ability. In contrast, methylation-deficient Top1 mutants (Top1KK) display impaired subnuclear mobility and accumulate elevated levels of trapped Top1–DNA covalent complexes (Top1cc) upon camptothecin (CPT) treatment. These defects are independent of PRMT5–Top1 binding but are dependent on PRMT5’s enzymatic activity. Loss of Top1 methylation—via point mutation, PRMT5 knockout, or pharmacological inhibition—delays Top1cc resolution and amplifies CPT-induced DNA damage. Strikingly, combining PRMT5 inhibitors (PRMT5i) with Top1 poisons such as irinotecan enhances cytotoxicity across multiple cancer cell types. In a triple-negative breast cancer mouse model, this combination significantly suppresses tumor growth and metastasis, accompanied by increased DNA damage. Our results define PRMT5-driven Top1 arginine methylation as a crucial regulatory mechanism and highlight PRMT5i as a means to potentiate Top1-based cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Biology, School of Biological Sciences, Indian Association for the Cultivation of Science, 2A & B, Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India.
- Division of Cancer Biology, Council of Scientific and Industrial Research-Central Drug Research Institute, Lucknow 226031, India.
- Technical Research Centre, S. N. Bose National Centre for Basic Sciences, Salt Lake, Kolkata 700106, India.
- Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh 201002, India.
- Department of Cell and Molecular Biology, Karolinska Institute, Stockholm 17177, Sweden.
ORCID-Profile: Arpan Bhattacharyya, Uttam Pal, Laura Baranello, Benu Brata Das
Förderung
- ANRF
- ICMR
- IACS
- UGC-NET
- Knut och Alice Wallenbergs Stiftelse
- Swedish Research Council
- Cancerfonden
Zitieren
APA
Basu, S., Bhattacharyya, A., Khan, M. A., Pal, U., Chowdhuri, S. P., Satrusal, S. R., Baranello, L., Datta, D., & Das, B. B. (2026). Arginine methylation of human DNA topoisomerase I by PRMT5 facilitates DNA relaxation. Nucleic Acids Research, 54(10). https://doi.org/10.1093/nar/gkag503
Vancouver
Basu S, Bhattacharyya A, Khan MA, Pal U, Chowdhuri SP, Satrusal SR, et al. Arginine methylation of human DNA topoisomerase I by PRMT5 facilitates DNA relaxation. Nucleic Acids Research. 2026;54(10). doi:10.1093/nar/gkag503
BibTeX
@article{Basu2026,
author = {Basu, Saini and Bhattacharyya, Arpan and Khan, Muqtada Ali and Pal, Uttam and Chowdhuri, Srijita Paul and Satrusal, Saumya Ranjan and Baranello, Laura and Datta, Dipak and Das, Benu Brata},
title = {Arginine methylation of human DNA topoisomerase I by PRMT5 facilitates DNA relaxation},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {10},
doi = {10.1093/nar/gkag503}
}
EUVIMED